Delivery Order SPE2DB20D2104-SPE2DB22FT57B
- Not listed
- This federal contract award, valued at $1,794.38, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Humira (CF) Pen 40 mg/0.4 mL, a specialty medication used for various medical conditions. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply Humira (CF) Pen 40 mg/0.4 mls pharmaceutical products. The $2,770.74 award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 to provide a comprehensive range of medications and medical supplies to military treatment programs and facilities worldwide. The IDC was awarded...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,385.37 firm fixed-price delivery order contract is for the supply of Humira (CF) Pen 40 mg/0.4 mL medication. The contract has an ultimate completion date of May 24, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop...
- This federal contract award from the Defense Logistics Agency (DLA) was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Humira(CF) Pen 40 mg/0.4 mL. The $33,380.06 firm fixed-price delivery order has a completion date of November 13, 2024 and is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a...
- This federal contract award is for the delivery of Humira (CF) Pen 40 mg/0.4 mL pharmaceutical products to the Defense Logistics Agency (DLA). The $5,486.46 Firm Fixed Price contract was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceuticals and medical supplies to the U.S. government. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 2025. This...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS medication. The $5,769.18 firm fixed-price delivery order contract has an ultimate completion date of October 23, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- This federal contract award, valued at $1,473.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Humira (CF) Pen 40 mg/0.4 mL, a specialty medication, to support military healthcare programs. The award is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, covers the delivery of Humira (CF) Pen 40 mg/0.4 mL to the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $5,541.48, is a firm fixed-price delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc. The IDC with the DLA is valued at up to $999,999,999.00 and runs through November 2026, providing a comprehensive range of...
- This federal contract award, valued at $1,510.60, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Humira (CF) Pen 40 mg/0.4 mL, a pharmaceutical product. The contract is a delivery order, with a firm fixed price pricing type, and has an ultimate completion date of April 29, 2025. It is not designated as a set-aside contract, indicating open competition....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Humira Pen 40 mg/0.8 mls. The contract has a ceiling value of $3,523.32 and an ultimate completion date of September 22, 2021. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB22FT57BDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Humira (CF) Pen 40 mg/0.4 mL. The contract, valued at $3,523.32, is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which is valued at $999,999,999 and runs through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. In addition to the DLA contract, AmerisourceBergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 8/9/22 |